XML 26 R17.htm IDEA: XBRL DOCUMENT v3.25.2
Goodwill and Intangible Assets
12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets

NOTE 7 – GOODWILL AND INTANGIBLE ASSETS

The Company’s goodwill relates to the AxoBio Acquisition. Goodwill represents the excess of the purchase price of the acquired business over the fair value of the underlying net tangible and intangible assets. The Company may record goodwill adjustments pursuant to changes in the preliminary valuations acquired during the measurement period, which is up to one year from the date of acquisition. For the year ended December 31, 2023, the Company recognized $19,188,278 in goodwill from the AxoBio Acquisition, which is classified as a component of assets available for sale in the accompanying consolidated balance sheets.

 

The Company’s intangible assets primarily relate to the AxoBio Acquisition (see Note 3). Intangible assets acquired in connection with the AxoBio Acquisition were initially recorded at their estimated fair value as of the acquisition date. Intangible assets that have finite lives are amortized over their economic useful life. Amortization of intangibles related to AxoBio is included as a component of discontinued operations in the accompanying consolidated statements of operations.

 

Additionally, the Company capitalizes legal costs directly associated with the submission of Company patent applications. Gross patent costs of $70,746 as of December 31, 2024 and 2023 are amortized on a straight-line basis over the patent term.

 

Intangible assets and the related accumulated amortization consist of the following at December 31, 2024:

 

 

Amortization Period

 

Gross Carrying Value

 

Accumulated Amortization

 

Net Book Value

Continuing operations:

 

 

 

 

 

 

 

Patents

16 years

 

$70,746

 

$51,105

 

$19,641

 

Intangible assets and the related accumulated amortization consist of the following at December 31, 2023:

 

 

Amortization Period

 

Gross Carrying Value

 

 

Accumulated Amortization

 

 

Net Book Value

 

Continuing operations:

 

 

 

 

 

 

 

 

 

 

Patents

16 years

 

$

70,746

 

 

$

46,559

 

 

$

24,187

 

 

 

 

 

 

 

 

 

 

 

 

Discontinued operations:

 

 

 

 

 

 

 

 

 

 

Customer contracts

20 years

 

$

12,170,000

 

 

$

337,313

 

 

$

11,832,687

 

Trade name

7 years

 

 

2,220,000

 

 

 

132,143

 

 

 

2,087,857

 

Intellectual property

7 years

 

 

8,870,000

 

 

 

527,976

 

 

 

8,342,024

 

 

 

 

$

23,260,000

 

 

$

997,432

 

 

$

22,262,568

 

 

Amortization expense included in loss from continuing operation in the accompanying consolidated statements of operations was approximately $4,546 and $4,515 for the years ended December 31, 2024 and 2023, respectively. Amortization expense included in income from discontinued operation in the accompanying consolidated statements of operations was $625,621 and $997,432 for the years ended December 31, 2024 and 2023, respectively.

 

Amortization expense related to the Company’s intangible assets for future years is as follows:

 

2025

$

4,546

 

2026

 

4,546

 

2027

 

4,021

 

2028

 

2,448

 

2029

 

2,448

 

Thereafter

 

1,632

 

 

$

19,641